Glenmark Pharmaceuticals is instructed by the CDSCO Panel to submit a Phase III CT Protocol regarding diabetic FDC.

Published Date: 16 Oct 2023

New Delhi: Mentioning the fixed-dose combination (FDC) of the diabetes medication metformin HCl, glimepiride, and the tablet form of lobeglitazone sulfate.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Make the Diagnosis: Can You Explain Her Rash and Conjunctival Injection?

2.

Health of Myeloma Patient's Marriage Tied to Recovery After Transplant

3.

In high-risk muscle invasive urothelial cancer, adjuvant pembrolizumab improves disease-free survival.

4.

In-person and Virtual Palliative Care Are Both Beneficial for Advanced Lung Cancer Patients.

5.

From sweetener to cancer fighter? Fermented stevia shows promise in pancreatic cancer study


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot